First approved by the FDA in 2009 for the treatment of type II diabetes, Onglyza, active ingredient saxagliptin, is a popular prescription medication. Onglyza works by preventing the liver from creating excess sugar, and by helping the pancreas to secrete insulin. Despite being a favorite amongst patients and doctors throughout the U.S., Onglyza and other DPP-4 inhibitors have dangerous side effects.<\/p>\n
<\/p>\n
The current Food & Drug Administration medication guide<\/a> for Onglyza carries a warning that taking Onglyza can lead to pancreatitis (inflammation of the pancreas). And in April of 2015, the FDA also supported Onglyza carrying a safety warning for the risk of heart failure<\/a> based on a finding that those who took Onglyza had a 27 percent greater risk of heart failure. In addition to pancreatitis and heart failure, another serious side effect of taking Onglyza is pancreatic cancer.<\/p>\n <\/p>\n Because many people took Onglyza without knowing of the associated risks of pancreatic cancer, pancreatitis, and heart failure, and suffered harm as a result, many have chosen to file lawsuits directly against Onglyza\u2019s manufacturer, AstraZeneca. These lawsuits allege that Onglyza did not conduct proper safety tests prior to releasing the drug, or\/and did not adequately provide warning of the drug\u2019s risks.<\/p>\n <\/p>\n Filing a lawsuit against the maker of a defective drug can yield damages for pain and suffering, medical expenses, lost wages, and other economic and noneconomic losses. But filing a lawsuit against a large pharmaceutical company can be complicated, and without a legal professional on your side, the chances of making a costly error are high.<\/p>\nLawsuits Filed Against Onglyza\u2019s Maker<\/h3>\n
Why You Need a Defective Drug Attorney<\/h3>\n